Similar Articles |
|
Chemistry World February 12, 2014 Amy Middleton-Gear |
Neutralizing heparin without complications Recovering from operations could become easier thanks to a self-assembling multivalent heparin binding agent being developed by scientists in the UK, Italy and Spain. |
Chemistry World September 17, 2013 Laura Howes |
What happens when you perturb the system? David Smith is a professor of chemistry at the University of York in the UK. His research explores how supramolecular chemistry can make molecular-scale building blocks self-assemble into nanostructures. He also has a passion for educational outreach. |
Chemistry World August 7, 2015 Suzanne Howson |
Simple probe for heparin quality control Scientists in China have developed a fluorescent probe to detect both heparin and its major contaminant. The sensor could make it easier to monitor the quality of heparin supplies. |
Chemistry World October 28, 2011 James Urquhart |
Simpler Enzymatic Route to Synthetic Heparin US scientists have demonstrated a potentially cheaper way of creating ultra low molecular weight heparin, a synthetic blood thinning agent primarily used to treat deep vein thrombosis and pulmonary embolism. |
Chemistry World August 19, 2008 Ananyo Bhattacharya |
Flask synthesis promises untainted heparin US researchers have created milligrams of pure heparin using enzymes and chemicals - a practical laboratory synthesis that could avoid the contamination issues surrounding the blood-thinning drug |
Chemistry World January 18, 2013 Emma Eley |
New method to target malaria Malaria affects millions of people each year; however, no effective vaccines exist. Now, scientists from Spain have discovered a new strategy to target the disease. |
The Motley Fool April 10, 2008 Brian Orelli |
The News for Baxter Just Got Worse These heparin-related deaths aren't associated with Baxter's product, but they still might spell trouble for the company. |
Nursing February 2012 Pezzotti & Freuler |
Using anticoagulants to steer clear of clots This article will review coagulation and provide important information about several commonly used anticoagulants and their reversal agents. |
The Motley Fool March 7, 2008 Brian Lawler |
A Little Too Much Drug Variability Another drugmaker has to recall batches of its compound. |